It is not clear that large pharmaceutical companies will want to participate in a program that so clearly promotes generic alternatives. In the era of electronic medical records, the prescription pad is becoming obsolete. This fact makes the proposed innovation potentially anachronistic. How does the project seek to respond to new technological progress?
Comments
It is not clear that large pharmaceutical companies will want to participate in a program that so clearly promotes generic alternatives. In the era of electronic medical records, the prescription pad is becoming obsolete. This fact makes the proposed innovation potentially anachronistic. How does the project seek to respond to new technological progress?
Thank you,
Changemakers Team
Post new comment